ContractWarrant Agreement • September 4th, 2020 • Celsion CORP • Pharmaceutical preparations • Delaware
THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR ANY STATE SECURITIES LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT.
FIRST amendment of VENTURE LOAN AND SECURITY AGREEMENTVenture Loan and Security Agreement • September 4th, 2020 • Celsion CORP • Pharmaceutical preparations • Connecticut
This FIRST AMENDMENT OF VENTURE LOAN AND SECURITY AGREEMENT (this “Agreement”), dated as of August 1, 2020, is entered into by and among Celsion Corporation (“Borrower”), Horizon Funding I, LLC (“HFI”) as an assignee of Horizon Technology Finance Corporation (“Horizon”), Horizon Funding Trust 2019-1 (“Horizon Trust” and collectively with HFI, “Lenders”), as an assignee of Horizon, and Horizon as Collateral Agent.
